Abstract
During 1994, 603 cases of bacterial meningitis were reported in Italy. Seventy-five percent of cases with determined etiology was due to three agents: Neisseria meningitidis (33.4%), Streptococcus pneumoniae (23.4%) and Haemophilus influenzae (18.6%). The majority of cases due to N. meningitidis and H. influenzae occurred in subjects below five years of age (35.7% and 84.8%, respectively) while S. pneumoniae accounted for 52.8% of meningitis cases in subjects older than 44 year of age. The estimated incidence of N. meningitidis on the national population in 1994 was 0.27 per 100,000. Serogroup B accounted for 62.5% of the serotyped isolates, group C for 23.1%, group A for 7.2%, group W135 for 3.6%, group Y for 1.8%. All tested meningococcal strains were susceptible to penicillin as well as to rifampin. Incidence of meningococcal meningitis in 1994 has been low suggesting that its relative importance compared to other bacteria causing meningitis is likely to change in the future. Therefore, extended surveillance on bacterial meningitis by other etiological agents has to be maintained and implemented in order to undertake the appropriate control measures and evaluate their effect.
Similar content being viewed by others
References
Noah N. Surveillance of bacterial meningitis in Europe 1993. King's College London, November 1994.
Stroffolini T, Congiu ME, Occhionero M, et al. Meningococcal disease in Italy. J Infect 1989; 19: 69–74.
Stroffolini T, Carbonari P. Meningococcal disease in Italy in 1989. Eur J Epidemiol 1992; 8: 114–116.
Stroffolini T. Vaccination campaign against meningococcal disease in army recruits in Italy. Epidemiol Infect 1990; 105: 579–583.
Italia DM. 15 Dicembre 1990: Sistema informativo delle malatie infettive e diffusive. Gazzetta Ufficiale, 8 January 1991.
EPI INFO Version 5.1b. Epidemiology Programme Office, Centers for Disease Control, Atlanta, GA, March 1991.
Abdillahi H, Poolman J. Whole-cell ELISA for typing N. meningitidis with monoclonal antibodies. FEMS Microbiol Lett 1987; 48: 367–371.
Hughes JH, Biedenbach DJ, Erwin ME, et al. E test as susceptibility test and epidemiologic tool for evaluation of Neisseria meningitidis isolates. J Clin Microbiol 1993; 31: 3255–3259.
Campos J, Trujillo G, Seuba T, et al. Discriminative criteria for Neisseria meningitidis isolates that are moderately susceptible to penicillin and amplicillin. Antimicrob Agents Chemother 1992; 36: 1028–1031.
National Committee for Clinical Laboratory Standards. 3rd edn; Approved Standard, Villanova, Pa. 1993.
Italia, ISTAT. Annuario Statistico Italiano, 1992: 516.
Stroffolini T, Curianò CM, Congiu ME, et al. Trends in meningococcal disease in Italy 1987. Publ Health 1989; 103: 31–34.
Anderson EL, Bowers T, Mink CM, et al. Safety and immunogenicity of meningococcal A and C polysaccharide conjugate vaccine in adults. Infection and Immunity 1994; 62: 3391–3395.
Gotschlich EC, Goldschneider I, Artenstein MS. Human immunity to the meningococcus, V: The effect of the immunization with meningococcal group C polysaccharide on the carrier state. J Exp Med 1969; 129: 1385–1395.
Jackson LA, Tenover FC, Baker C, et al. Prevalence of Neisseria meningitidis relatively resistant to penicillin in the USA, 1991. J Infect Dis 1993; 169: 438–441.
Saez-Nieto JA, Lujan R, Berron S, et al. Epidemiology and molecular basis of penicillin-resistant Neisseria meningitidis in Spain: A 3 year history (1985–1989). Clin Infect Dis 1992; 14: 394–402.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Salmaso, S., Mastrantonio, P., Scuderi, G. et al. Pattern of bacterial meningitis in Italy, 1994. Eur J Epidemiol 13, 317–321 (1997). https://doi.org/10.1023/A:1007303502274
Issue Date:
DOI: https://doi.org/10.1023/A:1007303502274